Role of Radiotherapy in the treatment of Metastatic Head and Neck Cancer
[OncoTargets and Therapy] A review of the role of radiation therapy and potential prognostic factors for selecting patients for more radical treatment.
Head and Neck Cancer
9/11 Responders May Have Higher Head and Neck Cancer Risk
Authors call for ongoing monitoring, treatment of those initially exposed.
Evolutionary Role of Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Literature-based Network Meta-analysis
[Cancer Management and Research] This network meta-analysis seeks to establish the optimal treatment in advanced nasopharyngeal carcinoma (NPC).
Mindfulness-based Stress Reduction in Patients With Differentiated Thyroid Cancer Receiving Radioactive Iodine Therapy: A Randomized Controlled Trial
[Cancer Management and Research] This research examines the efficacy of mindfulness-based stress reduction (MBSR) on health-related quality of life, depression, and anxiety in patients with differentiated thyroid cancer receiving radioactive iodine therapy.
Toxicity Similar, But Overall Survival Poor in Cetuximab vs Cisplatin for HPV-Positive Oropharyngeal Cancer
In a randomized phase 3 trial, researchers sought to determine if cetuximab-based chemoradiotherapy could be a less-toxic alternative to cisplatin-based chemoradiotherapy in patients with HPV-positive oropharyngeal cancer.
Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC
Researchers determined the 5-year overall and disease-free survival for patients with CSCC of the head and neck who received adjuvant radiation therapy.
HNC Survivors Continue to Experience Chronic Systemic Symptoms at 1 Year or More Posttreatment
Researchers assessed self-reports of chronic systemic symptoms experienced by head and neck cancer survivors at least 1 year posttreatment.
Head and Neck Cancer Survivors Have Increased Suicide Risk
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.
Affordable Care Act Has Positive Impact on Outcomes Among Those With Head and Neck Cancer
A prospective study collected data on the impact of the ACA on percent insured and outcomes for patients with HNSCC in the first years of healthcare law.
Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer
Results of a population-based survey, presented at the 2018 ASCO Quality Care Symposium, revealed patients’ perceptions regarding choice of treatment of differentiated thyroid cancer (DTC).
Next post in Head and Neck Cancer
